Articles & Analysis
Week of 2026-W06
Business Post Weekly Intelligence Briefing
Week of 5–11 February 2026: Deals, Distress & Disruption Across Irish Business
Source: ARTICLES | Period: 2026-02-05 to 2026-02-11
Ireland Bets Big: €62.5m Medtech Raise, Bawag Eyes PTSB, and the Airport Cap Finally Falls
Over the past seven days, Irish business moved on three fronts simultaneously: a Galway medtech company closed the week's largest domestic funding round, an Austrian bank publicly confirmed its appetite for PTSB in a deal that could reshape Irish retail banking, and the Cabinet finally approved legislation to remove the 32-million passenger cap at Dublin Airport. Meanwhile, the Iseq fell 1% on Wednesday as global markets digested a stronger-than-expected US jobs report, and two Irish companies moved into liquidation — a reminder that not every Irish business story ends in a funding round.
By the Numbers
| Metric | Value | Signal |
|---|---|---|
| Neurent Medical Series C funding | €62.5m | Growth |
| Circit fintech raise | €18.4m | Growth |
| PTSB potential valuation range | €1.1bn–€2.26bn | Watch |
| Smurfit Westrock 2025 net sales | $31.17bn (+47% YoY) | Growth |
| Smurfit Westrock job cuts | 3,000 | Distress |
| Solar 21 investor losses | €250m+ | Distress |
| AIB 2026 NII forecast (Carraighill) | €3.9bn (+€160m vs consensus) | Standout |
| Dublin Airport 2025 passengers | 36m+ (+5.1% YoY) | Growth |
The Investigation: Deals, Distress & Dublin's Week in Business
The Business Post published 191 articles this week, with banking, aviation, and technology dominating the agenda. Alice O'Leary led all reporters with 69 articles, followed by Oisín Gaffey (16) and Matthew Joyce and Vish Gain (11 each). The week's stories cluster into five clear themes: Irish tech and medtech funding, banking consolidation, aviation infrastructure, corporate distress, and the global tariff shock rippling through multinationals with Irish operations.
Top Stories by Theme
| Story | Theme | Key Figure | Signal |
|---|---|---|---|
| Neurent Medical €62.5m Series C | Medtech Funding | €62.5m | Growth |
| Circit €18.4m fintech raise | Fintech Funding | €18.4m | Growth |
| Bawag eyes PTSB acquisition | Banking M&A | €1.1–2.26bn | Watch |
| Dublin Airport cap removal approved | Aviation Policy | 36m+ pax | Growth |
| Smurfit Westrock $31.17bn revenue | Corporate Results | $31.17bn | Mixed |
| Solar 21 winding up order | Distress | €250m+ | Distress |
| Nova Leah liquidation | Distress | €4m raised | Distress |
| Defamation reform bill passes | Legal/Regulatory | Decade-long | Structural |
| State Street eyes Denis O'Brien docklands | Commercial Property | €60/sqft | Watch |
| OpenAI hires EMEA sales chief in Dublin | Tech/AI | EMEA hub | Growth |
Sector Breakdown: Where the Coverage Fell
Financial Performance: Notable Companies in Coverage
| Company | Key Metric | Value | Context |
|---|---|---|---|
| Smurfit Westrock | 2025 Net Sales | $31.17bn | +47% YoY post-merger |
| AIB (Carraighill forecast) | 2026 NII | €3.9bn | +€160m vs consensus |
| Bank of Ireland (Carraighill) | 2026 NII | €3.55bn | Above €3.375bn consensus |
| Spotify | Q3 2025 Revenue | €4.5bn | +13% YoY, 290m subscribers |
| Coca-Cola | 2026 Profit Growth | 7–10% | 2025 op profit +11.5% |
| Ford | 2025 Tariff Hit | $900m | $2bn total tariff cost |
| Mattel | Q4 Op Profit | −11% | Shares -30% on results |
| Heineken | Job Cuts | 5,000–6,000 | Beer demand slump |
The Connections: What the Official Record Adds to This Week's Stories
Business Post coverage this week tells one story; official records tell another. When you cross-reference the week's biggest Irish stories against CRO filings, court records, and property data, a richer picture emerges — of companies with longer histories than their press releases suggest, of legal proceedings that complicate the growth narrative, and of structural patterns that individual stories cannot capture alone.
The Radar: Three Signals Worth Watching
The Deep Dive: Neurent Medical and the Anatomy of an Irish Medtech Scale-Up
Two companies this week command a closer look: Neurent Medical, whose €62.5m Series C is the largest Irish medtech raise of the week and a case study in how Irish life sciences companies build to scale; and Circit, whose CRO filing on the day of its funding announcement reveals the mechanics of a well-prepared institutional round.
Neurent Medical — A Decade of Galway R&D Reaches Commercial Scale
Neurent Medical Limited (CRO no. 573202) was incorporated on 9 December 2015 at Oran Point, Oranmore, Co. Galway. Its Neuromark device treats chronic rhinitis — a condition affecting millions worldwide — by targeting overactive posterior nasal nerves through a non-surgical procedure. CEO and co-founder Brian Shields has been on the CRO register since founding. The board includes US-based director Mark Fletcher (Asheville, NC) and UK-based Drew Burdon (Leeds), reflecting the international investor base that has backed the company through multiple rounds.
| Metric | Detail | Source |
|---|---|---|
| CRO Registration | 9 December 2015 | CRO |
| Address | Oran Point, Oranmore, Galway H91D7X2 | CRO |
| NACE Code | Other R&D on natural sciences | CRO |
| Series C Raise | €62.5m (Feb 2026) | Business Post |
| Lead Investor | MVM Partners (Boston) | Business Post |
| Co-investors | Sofinnova, EQT Life Sciences, Atlantic Bridge, Enterprise Ireland | Business Post |
| Charges Registered | 3 charges, October 2024 | CRO |
| Auditor Change | AI222237 to AI223937 (2025) | CRO |
The question for 2027: Can Neurent achieve the US commercial scale needed to justify a trade sale or IPO? The chronic rhinitis market is large but competitive. Watch for US physician adoption data and revenue figures in the next 12–18 months.
Key People This Period
| Name | Role | Notable Activity | Connections |
|---|---|---|---|
| Brian Shields | CEO, Neurent Medical | Closed €62.5m Series C; CRO secretary since 2015 | Neurent Medical |
| David Heath | CEO, Circit | Closed €18.4m raise; filed G1 same day as article | Circit Limited |
| Tony Smurfit | CEO, Smurfit Westrock | $31.17bn revenue; 3,000 job cuts; €7bn EBITDA target by 2030 | Smurfit Westrock |
| Colin Hunt | CEO, AIB | 3.5% pay deal with FSU; Carraighill forecasts €3.9bn NII | AIB |
| Willie Walsh | Director General, IATA | Called Dublin Airport cap "outdated"; wants early results from removal | Dublin Airport |
| Michael O'Leary | CEO, Ryanair | Criticised timing of cap removal; signed multi-billion CFM engine deal | Ryanair/CFM |
| Albert Manifold | Chair, BP | Suspended BP share buyback; investors disappointed despite in-line results | BP |
One to Watch: Circit Limited
Circit Limited
| Metric | Detail |
|---|---|
| Founded | 1 July 2015 |
| Latest Raise | €18.4m (Ten Coves Capital, Feb 2026) |
| Audit Network Reach | 400+ audit firms, all top-20 global networks |
| Bank Connections | 30,000+ banks and fund service providers |
| CRO Activity | G1 special resolution filed 11 Feb 2026 (same day as article) |
| Charges | 2 charges registered May 2024 |
What they do: Circit automates audit workflows by leveraging open banking to verify asset and liability ownership. It connects audit firms directly to financial institutions' systems, replacing the manual, paper-based confirmation process that has been standard in audit for decades.
Why it matters: Circit is a rare Irish B2B SaaS company with genuine global network effects — the more banks and audit firms join its network, the more valuable it becomes to all participants. Its adoption by all top-20 global audit networks is a significant competitive moat. CEO David Heath has been building this company for a decade from the IFSC. The CRO record shows the company filed its constitutional amendment on the same day the funding was announced — suggesting a clean, well-prepared close.
The number that matters: 30,000+ banks and fund service providers in the verification network. That is the moat. Every new audit firm that joins makes the network more valuable to every bank already on it, and vice versa. Watch for US bank API integrations announced in H2 2026.
The Broader Picture: Courts, Property & The Week Ahead
The Irish Courts
The High Court delivered 11 judgments this week, with three of particular relevance to business readers. The Revenue Commissioners tax avoidance case involving Gilt Forward Contracts and Foreign Exchange Contracts for Difference resulted in a significant finding largely in favour of taxpayers on the application of section 811 of the Taxes Consolidation Act 1997. The housing apartment design standards case was referred to the Court of Justice of the EU, adding further uncertainty to Ireland's planning environment. The Tinakilly hotel dispute — covered by the Business Post — continued in the High Court.
| Citation | Parties | Subject | Why It Matters |
|---|---|---|---|
| [2026] IEHC 59 | Hegarty, Geary, Ward v Revenue Commissioners | Tax avoidance — Gilt Forward Contracts, CGT | Taxpayers largely prevailed on s.811 anti-avoidance; significant for structured finance |
| [2026] IEHC 67 | McDonald v Minister for Housing [No.3] | Apartment design standards — EU SEA Directive | CJEU reference adds uncertainty to housing planning framework |
| [2026] IEHC 65 | Hoctor v An Coimisiún Pleanála | Planning challenge | Ongoing pressure on planning authority decisions |
| [2026] IEHC 71 | Chimwala v Residential Tenancies Board | Tenancy dispute | RTB jurisdiction and High Court oversight |
Property Markets & Plans
Dublin's residential property market recorded 230 transactions in the week of 5–11 February 2026, with an average price of €551,620 and a median of €482,379 — the median is a more reliable indicator, as the average is pulled up by a small number of high-value transactions (the maximum recorded was €2.2 million). The commercial property story of the week was State Street's reported move to Denis O'Brien's 2 Grand Canal Quay development, a 15-storey, 145,000 sq ft building in the Dublin Docklands, at approximately €60 per sq ft on a 15-year lease with a break at year 12.
| Property / Development | Value / Detail | Significance |
|---|---|---|
| Dublin residential market (week) | 230 transactions, avg €551,620 | Median €482,379 — market remains elevated |
| State Street / 2 Grand Canal Quay | 5,574–7,432 sqm, €60/sqft, 15yr lease | Major docklands office deal; Denis O'Brien development |
| College Green pedestrianisation | 17,000 sqm public space by 2029 | Dublin City Council planning application summer 2026 |
| Dublin Airport cap removal | 32m cap to be lifted | Infrastructure investment signal for aviation-adjacent property |
The Week Ahead
The week of 5–11 February 2026 was defined by three converging forces: Irish capital formation (two significant funding rounds), Irish banking consolidation (Bawag/PTSB), and Irish infrastructure policy (Dublin Airport cap). These are not unrelated — they all reflect the same underlying dynamic: Ireland is a small, open economy with a disproportionately large financial and technology sector, and the decisions made this week will shape its competitive position for the next decade. The defamation reform, the airport cap removal, and the banking consolidation are all structural changes that will take years to fully play out.
What to Watch: (1) Bawag's formal approach to PTSB — expect a bid or a withdrawal within six months. (2) Neurent Medical's US commercial launch — the €62.5m is the fuel; the question is whether the market is ready. (3) The Defamation Act's first High Court test — the first judge-only defamation trial will set the tone for damages awards under the new regime. (4) Dublin Airport cap legislation — watch for the Oireachtas timeline and any legal challenges from planning authorities.